Home › Companies › SAGE THERAPEUTICS INC. › 2024-2025

SAGE THERAPEUTICS INC. 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings and SAGE THERAPEUTICS INC.’s Form 8-K, filed 2025-06-13 (Item 5.07 on EDGAR). Page generated 04 October 2026.

5Ballot items
192Asset managers
894Fund votes
2025-06-11Meeting date

Proxy season: 2023-2024 2024-2025

Explore SAGE THERAPEUTICS INC. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by SAGE THERAPEUTICS INC.

These tallies are SAGE THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2025-06-13 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

SAGE THERAPEUTICS INC. — official shareholder meeting results, meeting held 2025-06-11
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Outcome
Elect Director: James M. Frates	35,830,348	--	--	11,423,692	3,926,582	Majority: yes
Elect Director: George Golumbeski, Ph.D.	26,051,703	--	--	21,202,337	3,926,582	Majority: yes
Proposal 2: The appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2025, was ratified.	50,479,676	684,081	16,865	--	--	Majority: yes
Proposal 3: A non-binding, advisory proposal on the compensation of the Company's named executive officers was approved.	35,986,261	10,918,957	348,822	--	3,926,582	Passed
Proposal 4: The amendment to the 2014 ESPP to increase the number of shares of the Company's common stock authorized for issuance thereunder by 500,000 shares was approved.	40,977,751	6,266,890	9,399	--	3,926,582	Passed

Source: SAGE THERAPEUTICS INC., Form 8-K, filed with the SEC on 2025-06-13 — read the filing on EDGAR.

How asset managers voted at the SAGE THERAPEUTICS INC. 2024-2025 meeting

Each item below shows how the 192 asset managers that disclosed a SAGE THERAPEUTICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.

1. TO HOLD A NON-BINDING ADVISORY VOTE TO APPROVE THE COMPENSATION PAID TO OUR NAMED EXECUTIVE OFFICERS.

SECTION 14A SAY-ON-PAY VOTESCompany result: Passed

Combines 8 wordings of this item as funds reported it.

77% Passed · of votes cast

FOR 77%AGAINST 23%

FOR: 35,986,261AGAINST: 10,918,957

SAGE THERAPEUTICS INC.’s own tally for this item (“Proposal 3: A non-binding, advisory proposal on the compensation of the Company's named executive officers was approved.”): 35,986,261 for, 10,918,957 against — passed, per its Form 8-K filed 2025-06-13 (Item 5.07).

The 189 asset managers below cast 75% of the shares they voted on this item FOR (32,244,808 for, 10,627,575 against).

FOR 75%AGAINST 25%

FOR: 32,244,808 (75.2%)AGAINST: 10,627,575 (24.8%)

Largest asset managers voting on “TO HOLD A NON-BINDING ADVISORY VOTE TO APPROVE THE COMPENSATION PAID TO OUR NAMED EXECUTIVE OFFICERS.” at SAGE THERAPEUTICS INC., 2024-2025
Asset manager	For	Against	Vote
Madison Avenue Partners, LP	0	5,441,384	Against
Vanguard	5,399,389	0	For
BlackRock	4,209,771	0	For
Caligan Partners LP	0	3,052,558	Against
Deep Track Capital, LP	2,498,505	0	For
TIG Advisors, LLC	2,286,159	0	For
Federated Hermes	2,275,882	0	For
BOOTHBAY FUND MANAGEMENT, LLC	0	1,384,465	Against
GEODE CAPITAL MANAGEMENT, LLC	1,315,287	0	For
Fidelity	1,301,472	0	For
MARSHALL WACE, LLP	1,243,576	0	For
DE Shaw	1,177,600	0	For
State Street	1,095,102	0	For
Charles Schwab	906,252	0	For
HARVEST MANAGEMENT LLC	867,488	0	For
AQR	838,693	0	For
Nuveen	598,305	0	For
TIAA	592,585	0	For
ADAR1 Capital Management, LLC	528,423	0	For
Citadel	505,108	0	For
Northern Trust	418,728	0	For
JACOBS LEVY EQUITY MANAGEMENT, INC	331,457	0	For
Rangeley Capital, LLC	0	329,076	Against
Hudson Bay Capital Management LP	298,694	0	For
Renaissance	278,706	0	For

Showing the 25 largest of 189 asset managers. See all 189 in the interactive database.

2. To elect two directors, James M. Frates and George Golumbeski, Ph.D., each to serve as a Class II director until the 2028 Annual Meeting of Stockholders and until his successor is duly elected and qualified, subject to his earlier death, resignation, or removal: George Golumbeski, Ph.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

55% Majority: yes · of votes cast

FOR 55%WITHHELD 45%

FOR: 26,051,703WITHHELD: 21,202,337

SAGE THERAPEUTICS INC.’s own tally for this item (“Elect Director: George Golumbeski, Ph.D.”): 26,051,703 for, 21,202,337 withheld, per its Form 8-K filed 2025-06-13 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

The 54 asset managers below cast 100% of the shares they voted on this item FOR (8,752,945 for, 0 against).

FOR 71%ABSTAIN 29%

FOR: 8,752,945 (70.9%)ABSTAIN: 3,587,461 (29.1%)

Largest asset managers voting on “To elect two directors, James M. Frates and George Golumbeski, Ph.D., each to serve as a Class II director unt” at SAGE THERAPEUTICS INC., 2024-2025
Asset manager	For	Abstain	Vote
Vanguard	5,151,911	202,100	For
BlackRock	0	2,232,281	Abstain
Fidelity	1,166,736	129,820	For
Federated Hermes	1,081,617	0	For
TIAA	592,585	0	For
Charles Schwab	453,126	0	For
Equitable	0	146,013	Abstain
American Century	0	124,850	Abstain
Nationwide	0	111,156	Abstain
QUANTITATIVE MASTER SERIES LLC	0	91,506	Abstain
Columbia Threadneedle	84,836	0	For
AdvisorShares Trust	0	83,642	Abstain
Dimensional	0	64,846	Abstain
ETFis Series Trust I	0	63,321	Abstain
Voya	0	48,773	Abstain
Northern Lights Fund Trust IV	43,194	0	For
Lincoln Financial	39,400	3,729	For
Jackson National	0	34,169	Abstain
Northern Trust	0	33,533	Abstain
Global X	32,172	0	For
Invesco	0	30,648	Abstain
Pacific Life	0	28,575	Abstain
AIG/SunAmerica	0	27,903	Abstain
Bridge Builder Trust	0	24,707	Abstain
GuideStone	0	24,522	Abstain

Showing the 25 largest of 54 asset managers. See all 54 in the interactive database.

3. To elect two directors, James M. Frates and George Golumbeski, Ph.D., each to serve as a Class II director until the 2028 Annual Meeting of Stockholders and until his successor is duly elected and qualified, subject to his earlier death, resignation, or removal: James M. Frates

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

76% Majority: yes · of votes cast

FOR 76%WITHHELD 24%

FOR: 35,830,348WITHHELD: 11,423,692

SAGE THERAPEUTICS INC.’s own tally for this item (“Elect Director: James M. Frates”): 35,830,348 for, 11,423,692 withheld, per its Form 8-K filed 2025-06-13 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

The 54 asset managers below cast 100% of the shares they voted on this item FOR (12,187,327 for, 0 against).

FOR 99%

FOR: 12,187,327 (98.8%)ABSTAIN: 153,079 (1.2%)

Largest asset managers voting on “To elect two directors, James M. Frates and George Golumbeski, Ph.D., each to serve as a Class II director unt” at SAGE THERAPEUTICS INC., 2024-2025
Asset manager	For	Abstain	Vote
Vanguard	5,354,011	0	For
BlackRock	2,232,281	0	For
Fidelity	1,296,556	0	For
Federated Hermes	1,081,617	0	For
TIAA	592,585	0	For
Charles Schwab	453,126	0	For
Equitable	86,113	59,900	For
American Century	124,850	0	For
Nationwide	111,156	0	For
QUANTITATIVE MASTER SERIES LLC	91,506	0	For
Columbia Threadneedle	84,836	0	For
AdvisorShares Trust	83,642	0	For
Dimensional	0	64,846	Abstain
ETFis Series Trust I	63,321	0	For
Voya	48,773	0	For
Northern Lights Fund Trust IV	43,194	0	For
Lincoln Financial	39,400	3,729	For
Jackson National	22,577	11,592	For
Northern Trust	33,533	0	For
Global X	32,172	0	For
Invesco	30,648	0	For
Pacific Life	28,575	0	For
AIG/SunAmerica	27,903	0	For
Bridge Builder Trust	24,707	0	For
GuideStone	24,522	0	For

Showing the 25 largest of 54 asset managers. See all 54 in the interactive database.

4. To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.

AUDIT-RELATEDMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%

FOR: 50,479,676AGAINST: 684,081

SAGE THERAPEUTICS INC.’s own tally for this item (“Proposal 2: The appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2025, was ratified.”): 50,479,676 for, 684,081 against, per its Form 8-K filed 2025-06-13 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

The 54 asset managers below cast 99.9% of the shares they voted on this item FOR (12,339,300 for, 1,106 against).

FOR 99.9%

FOR: 12,339,300 (100.0%)AGAINST: 1,106 (0.0%)

Largest asset managers voting on “To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm f” at SAGE THERAPEUTICS INC., 2024-2025
Asset manager	For	Vote
Vanguard	5,354,011	For
BlackRock	2,232,281	For
Fidelity	1,296,556	For
Federated Hermes	1,081,617	For
TIAA	592,585	For
Charles Schwab	453,126	For
Equitable	146,013	For
American Century	124,850	For
Nationwide	111,156	For
QUANTITATIVE MASTER SERIES LLC	91,506	For
Columbia Threadneedle	84,836	For
AdvisorShares Trust	83,642	For
Dimensional	64,846	For
ETFis Series Trust I	63,321	For
Voya	48,773	For
Northern Lights Fund Trust IV	43,194	For
Lincoln Financial	43,129	For
Jackson National	34,169	For
Northern Trust	33,533	For
Global X	32,172	For
Invesco	30,648	For
Pacific Life	28,575	For
AIG/SunAmerica	27,903	For
Bridge Builder Trust	24,707	For
GuideStone	24,522	For

Showing the 25 largest of 54 asset managers. See all 54 in the interactive database.

5. TO APPROVE AN AMENDMENT TO OUR 2014 EMPLOYEE STOCK PURCHASE PLAN, AS AMENDED, OR THE 2014 ESPP, TO INCREASE THE NUMBER OF SHARES OF OUR COMMON STOCK AUTHORIZED FOR ISSUANCE UNDER THE 2014 ESPP BY 500,000 SHARES.

COMPENSATIONCompany result: Passed

87% Passed · of votes cast

FOR 87%13%

FOR: 40,977,751AGAINST: 6,266,890

SAGE THERAPEUTICS INC.’s own tally for this item (“Proposal 4: The amendment to the 2014 ESPP to increase the number of shares of the Company's common stock authorized for issuance thereunder by 500,000 shares was approved.”): 40,977,751 for, 6,266,890 against — passed, per its Form 8-K filed 2025-06-13 (Item 5.07).

The 54 asset managers below cast 100% of the shares they voted on this item FOR (12,393,084 for, 0 against).

FOR 100%

FOR: 12,393,084 (100.0%)

Largest asset managers voting on “TO APPROVE AN AMENDMENT TO OUR 2014 EMPLOYEE STOCK PURCHASE PLAN, AS AMENDED, OR THE 2014 ESPP, TO INCREASE TH” at SAGE THERAPEUTICS INC., 2024-2025
Asset manager	For	Vote
Vanguard	5,354,011	For
BlackRock	2,232,281	For
Fidelity	1,296,556	For
Federated Hermes	1,081,617	For
TIAA	592,585	For
Charles Schwab	453,126	For
Equitable	146,013	For
American Century	124,850	For
Nationwide	111,156	For
QUANTITATIVE MASTER SERIES LLC	91,506	For
Columbia Threadneedle	84,836	For
AdvisorShares Trust	83,642	For
Boussard & Gavaudan Investment Management LLP	77,200	For
Dimensional	64,846	For
ETFis Series Trust I	63,321	For
Voya	48,773	For
Northern Lights Fund Trust IV	43,194	For
Lincoln Financial	43,129	For
Jackson National	34,169	For
Northern Trust	33,533	For
Global X	32,172	For
Invesco	30,648	For
Pacific Life	28,575	For
AIG/SunAmerica	27,903	For
Bridge Builder Trust	24,707	For

Showing the 25 largest of 54 asset managers. See all 54 in the interactive database.

Largest SAGE THERAPEUTICS INC. shareholders voting in 2024-2025

Ranked by the number of SAGE THERAPEUTICS INC. shares each manager voted on the most widely held ballot item of the 2024-2025 meeting.

Top SAGE THERAPEUTICS INC. shareholders by shares voted, 2024-2025
#	Asset manager	Shares voted
1	Madison Avenue Partners, LP	5,441,384
2	Vanguard	5,399,389
3	BlackRock	4,209,771
4	Caligan Partners LP	3,052,558
5	Deep Track Capital, LP	2,498,505
6	TIG Advisors, LLC	2,286,159
7	Federated Hermes	2,275,882
8	BOOTHBAY FUND MANAGEMENT, LLC	1,384,465
9	GEODE CAPITAL MANAGEMENT, LLC	1,315,287
10	Fidelity	1,301,472

Shown as share counts, not percentages: no shares-outstanding figure has been matched to SAGE THERAPEUTICS INC. for the 2024-2025 season, so there is no denominator to divide by.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. This page is a static snapshot rebuilt weekly on 04 October 2026; a live search always shows the current data.

At SAGE THERAPEUTICS INC.'s shareholder meeting held 2025-06-11, in the 2024-2025 proxy season, 192 asset managers reported how they voted on 5 ballot items in their SEC Form N-PX filings, covering 894 separate fund positions. On the most widely held item on that ballot — TO HOLD A NON-BINDING ADVISORY VOTE TO APPROVE THE COMPENSATION PAID TO OUR NAMED EXECUTIVE… — the proposal passed with 77% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: SAGE THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2025-06-13.

SAGE THERAPEUTICS INC. proxy season coverage: 2023-2024 · 2024-2025 (this page).